Literature DB >> 353255

Exogenous prostaglandins and gastric secretion in the cat.

R Baker, B M Jaffe, J D Reed, B Shaw, C W Venables.   

Abstract

1. In the conscious gastric fistula cate PGE2 was shown to produce dose-related inhibition of gastric acid and pepsin secreted in response to pentagastrin, histamine and insulin. 2. PGF2alpha had little effect on pentagastrin-stimulated gastric acid and pepsin secretion. 3PGF2 delayed the tachyphylaxis of gastric acid stimulated by pentagastrin and histamine, but not that stimulated by insulin. 4. Although not delaying tachyphylaxis of insulin stimulated acid, PGE2 delayed tachyphylaxis of insulin stimulated pepsin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 353255      PMCID: PMC1282360          DOI: 10.1113/jphysiol.1978.sp012315

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  16 in total

1.  Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man.

Authors:  S J Konturek; J Biernat; J Oleksy
Journal:  Am J Dig Dis       Date:  1974-07

2.  Comparison of prostaglandin E1 and norepinephrine on the gastric mucosal circulation.

Authors:  E D Jacobson
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

3.  Release of prostaglandin E-1 from the rat stomach.

Authors:  A Bennett; C A Friedmann; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

Review 4.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

5.  Occurrence of prostaglandin E2 in the human stomach, and a study of its effects on human isolated gastric muscle.

Authors:  A Bennett; J G Murray; J H Wyllie
Journal:  Br J Pharmacol Chemother       Date:  1968-02

6.  Proceedings: Effects of prostaglandin E2 on rat gastric mucosal blood flow, as determined by 14C-aniline clearance.

Authors:  I H Main; B J Whittle
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

Review 7.  Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.

Authors:  A Robert; J R Schultz; J E Nezamis; C Lancaster
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Effects of isopropylnoradrenaline on tachyphylaxis of gastrin stimulated gastric acid secretion and mucosal blood flow in the anaesthetized cat.

Authors:  J D Reed; J R Smy
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

9.  The effects of somatostatin and metiamide on tachyphylaxis of pentagastrin stimulated gastric acid and pepsin secretion in the conscious cat.

Authors:  M Albinus; E L Blair; B H Hirst; J D Reed; A V Schally; B Shaw
Journal:  J Physiol       Date:  1977-04       Impact factor: 5.182

10.  Inhibition by prostaglandin E 1 of gastric secretion in the dog.

Authors:  J E Nezamis; A Robert; D F Stowe
Journal:  J Physiol       Date:  1971-10       Impact factor: 5.182

View more
  5 in total

1.  Are prostaglandins involved in somatostatin mediated inhibition of gastric secretion in the cat?

Authors:  M Albinus; G Frisch
Journal:  Agents Actions       Date:  1986-04

2.  Stimulated gastric prostaglandin output, and the effect of inhibition of prostaglandin synthetase, in the conscious cat.

Authors:  R Baker; B M Jaffe; B Shaw; C W Venables
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

3.  Endogenous prostaglandins and gastric secretion in the cat.

Authors:  R Baker; B M Jaffe; J D Reed; B Shaw; C W Venables
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

Review 4.  Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.

Authors:  B M Jaffe
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

5.  Endogenous prostaglandins in peptic ulcer disease.

Authors:  R Baker; B M Jaffe; C W Venables
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.